DSpace Repository

Browsing by Author "Chuquiyauri, R."

Browsing by Author "Chuquiyauri, R."

Sort by: Order: Results:

  • Lack of molecular correlates of Plasmodium vivax ookinete development 
    Bounkeua, V.; Li, F.; Chuquiyauri, R.; Abeles, S.R.; McClean, C.M.; Neyra, V.; Llanos Cuentas, Elmer Alejandro; Yori, P.P.; Vinetz, Joseph Michael (American Society of Tropical Medicine and Hygiene, 2011)
    Previous studies of Plasmodium vivax transmission to Anopheles spp. mosquitoes have not been able to predict mosquito infectivity on the basis of microscopic or molecular quantification of parasites (total parasites in the ...
  • Single-dose tafenoquine to prevent relapse of plasmodium vivax malaria 
    Lacerda, M.V.G.; Llanos Cuentas, Elmer Alejandro; Krudsood, S.; Lon, C.; Saunders, D.L.; Mohammed, R.; Yilma, D.; Pereira, D.B.; Espino, F.E.J.; Mia, R.Z.; Chuquiyauri, R.; Val, F.; Casapía, M.; Monteiro, W.M.; Brito, M.A.M.; Costa, M.R.F.; Buathong, N.; Noedl, H.; Diro, E.; Getie, S.; Wubie, K.M.; Abdissa, A.; Zeynudin, A.; Abebe, C.; Tada, M.S.; Brand, F.; Beck, H.-P.; Angus, B.; Duparc, S.; Kleim, J.-P.; Kellam, L.M.; Rousell, V.M.; Jones, S.W.; Hardaker, E.; Mohamed, K.; Clover, D.D.; Fletcher, K.; Breton, J.J.; Ugwuegbulam, C.O.; Green, J.A.; Koh, G.C.K.W. (Massachusetts Medical Society, 2019)
    BACKGROUND: Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites, but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a treatment termed "radical cure"). Tafenoquine ...
  • Socio-demographics and the development of malaria elimination strategies in the low transmission setting 
    Chuquiyauri, R.; Paredes, M.; Peñataro, P.; Torres, S.; Marin, S.; Tenorio, A.; Brouwer, K.C.; Abeles, S.; Llanos Cuentas, Elmer Alejandro; Gilman, Robert Hugh; Kosek, M.; Vinetz, Joseph Michael (Elsevier, 2012)
    This analysis presents a comprehensive description of malaria burden and risk factors in Peruvian Amazon villages where malaria transmission is hypoendemic. More than 9000 subjects were studied in contrasting village ...
  • Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria 
    Llanos Cuentas, Elmer Alejandro; Lacerda, M.V.G.; Hien, T.T.; Vélez, I.D.; Namaik-Larp, C.; Chu, C.S.; Villegas, M.F.; Val, F.; Monteiro, W.M.; Brito, M.A.M.; Costa, M.R.F.; Chuquiyauri, R.; Casapía, M.; Nguyen, C.H.; Aruachan, S.; Papwijitsil, R.; Nosten, F.H.; Bancone, G.; Angus, B.; Duparc, S.; Craig, G.; Rousell, V.M.; Jones, S.W.; Hardaker, E.; Clover, D.D.; Kendall, L.; Mohamed, K.; Koh, G.C.K.W.; Wilches, V.M.; Breton, J.J.; Green, J.A. (Massachusetts Medical Society, 2019)
    BACKGROUND: Tafenoquine, a single-dose therapy for Plasmodium vivax malaria, has been associated with relapse prevention through the clearance of P. vivax parasitemia and hypnozoites, termed "radical cure." METHODS: We ...
  • Whole genome sequencing analysis of Plasmodium vivax using whole genome capture 
    Bright, A.T.; Tewhey, R.; Abeles, S.; Chuquiyauri, R.; Llanos Cuentas, Elmer Alejandro; Ferreira, M.U.; Schork, N.J.; Vinetz, Joseph Michael; Winzeler, E.A. (BioMed Central, 2012)
    Background: Malaria caused by Plasmodium vivax is an experimentally neglected severe disease with a substantial burden on human health. Because of technical limitations, little is known about the biology of this important ...

Search DSpace

Browse

My Account